Comparison of Elagolix and OCPs in Reducing Endometriosis Associated Pelvic Pain

Enrolling by invitation · Phase 4

Conditions studied: Endometriosis (Diagnosis)

In brief

This study is designed to provide direct evidence on the relative effectiveness and safety of Elagolix versus OCPs, helping physicians make more tailored treatment decisions.

Key facts

Study ID

NCT07532876

Run by

Pak Emirates Military Hospital

People needed

90

Starts

2026-05-01

Expected to finish

2026-11-01

Last updated by the study team

2026-04-16

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women aged 18-45 years
• clinically or surgically confirmed endometriosis
• having regular menstrual cycles
• willingness to participate with informed consent.

You may not qualify if…

• Contraindications to OCPs (e.g., thromboembolism, cardiovascular disease, uncontrolled hypertension, smoking over age 35)
• Contraindications to Elagolix (e.g., osteoporosis, pregnancy, hypersensitivity, severe depression) Prior hysterectomy or bilateral oophorectomy, Other identifiable causes of pelvic pain.

Where it is running

• Pak Emirates Military Hospital — Rawalpindi, Punjab Province, Pakistan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.